The Technical Analyst
Select Language :
Thermogenesis Holdings [THMO]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices

Thermogenesis Holdings Price, Forecast, Insider, Ratings, Fundamentals & Signals

Thermogenesis Holdings is listed at the  Exchange

-1.43% $0.703

America/New_York / 27 mar 2024 @ 16:00


Thermogenesis Holdings: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 2.21 mill
EPS: -7.22
P/E: -0.100
Earnings Date: Mar 28, 2024
SharesOutstanding: 3.14 mill
Avg Daily Volume: 0.0914 mill
RATING 2024-03-27
B+
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Strong Buy
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.100 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE -0.100 | industry: PE 222.16
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.603 - 0.803

( +/- 14.22%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-15 Xu Xiaochun Buy 4 113 158 Common Stock
2024-03-15 Xu Xiaochun Sell 0 Amendment 4 to 1st Amended & Restated Revolving Credit Agr.
2023-11-17 Xu Xiaochun Sell 600 000 Common Stock
2023-09-28 Xu Xiaochun Buy 654 206 Common Stock
2023-09-28 Xu Xiaochun Sell 0 Amendment 3 to 1st Amended & Restated Revolving Credit Agr.
INSIDER POWER
80.35
Last 97 transactions
Buy: 26 026 445 | Sell: 10 013 519

Forecast: 16:00 - $0.703

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.703
Forecast 2: 16:00 - $0.703
Forecast 3: 16:00 - $0.703
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.703 (-1.43% )
Volume 0.0119 mill
Avg. Vol. 0.0914 mill
% of Avg. Vol 13.02 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Thermogenesis Holdings Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Thermogenesis Holdings Inc

RSI

Intraday RSI14 chart for Thermogenesis Holdings Inc

Last 10 Buy & Sell Signals For THMO

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Thermogenesis Holdings Inc

THMO

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.

Last 10 Buy Signals

Date Signal @
TBTCUSDMar 28 - 04:0369 857
STSOLUSDMar 28 - 04:04215.88
PROMUSDMar 28 - 04:04$14.33
AKH.OLMar 27 - 08:05NOK3.10
WOOUSDMar 28 - 04:04$0.463
SFPUSDMar 28 - 04:04$0.783
STRKUSDMar 28 - 04:04$13.95
POLYXUSDMar 28 - 04:040.604
CHRUSDMar 28 - 04:04$0.478
BELUSDMar 28 - 04:040.973

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.